SM
COEPW

Skaana Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Skaana Management’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,180
Closed -$744 – 156
2024
Q1 		$744 Hold
29,180
– – ﹤0.01% 148
2023
Q4 		$905 Hold
29,180
– – ﹤0.01% 161
2023
Q3 		$659 Hold
29,180
– – ﹤0.01% 175
2023
Q2 		$2.04K Buy
+29,180
New +$3.48K ﹤0.01% 159
2022
Q4 		– Sell
-29,180
Closed -$1K – 181
2022
Q3 		$1K Hold
29,180
– – ﹤0.01% 103
2022
Q2 		$1K Sell
29,180
-5,000
-15% -$376 ﹤0.01% 116
2022
Q1 		$3K Hold
34,180
– – ﹤0.01% 119
2021
Q4 		$11K Buy
+34,180
New +$11.4K ﹤0.01% 177

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Skaana Management's COEPW Position: Q2 2024 in Review

Skaana Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2024, closing a stake of 29,180 shares — an estimated $744 sold.

Skaana Management first reported a position in COEPW in Q4 2021 and held it in 8 quarters. The position peaked at $11K in Q4 2021. 17 funds tracked by Wall St. Rank hold COEPW as of Q2 2024.

  • Skaana Management reported no remaining Coeptis Therapeutics Warrants position as of Q2 2024 after selling out during the quarter.
  • Skaana Management sold 29,180 Coeptis Therapeutics Warrants shares in Q2 2024, an estimated $744.
  • Skaana Management first reported a position in Coeptis Therapeutics Warrants in Q4 2021 and held it in 8 quarters.
  • Skaana Management's Coeptis Therapeutics Warrants position peaked at $11K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2024.

Based on Skaana Management's 13F filing for Q2 2024, filed 31 Jul 2024.